Latest Breaking News On - Event free survival or overall in patients with head and neck squamous cell carcinoma - Page 1 : comparemela.com

Administration of atezolizumab after definitive local therapy did not improve EFS or OS in patients with head and neck squamous cell carcinoma.

United statesDeborahj wongCalifornia los angeles schoolMiddle eastNorth americaHead amp neck cancersAtezolizumab after definitive local therapyEvent free survival or overall in patients with head and neck squamous cell carcinoma2024 aacr annual meeting